Over 150 Texas Medical Marijuana Qualifying Conditions

• 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
• 5-aminoimidazole-4-carboxamide ribonucleotide transformylase deficiency;
• Adenylosuccinate synthase Deficiency
• Alexander disease
• Alpers-Huttenlocher syndrome
• Alpha-fucosidosis
• Alzheimer’s Disease
• Amyloidoses
• Amyotrophic lateral Sclerosis
• Argyrophilic Grain Disease
• Aromatic L-amino acid decarboxylase deficiency
• Asparylglucosaminuria
• Ataxia neuropathy spectrum
• Bidirectional enzyme deficiency
• Canavan disease
• Central Core Muscular Dystrophy
• Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy
• Charcot Marie Tooth and related hereditary neuropathies
• Childhood Myocerebrohepatopathy spectrum
• Chronic Traumatic Encephalopathy
• Congenital Disorders of Glycosylation
• Corticobasal Degeneration
• Creatine Transporter Defect, also known as SLC 6A8
• Creutzfeldt-Jakob Disease
• Dementia with Lewy Bodies
• Deoxyguanisine kinase deficiency
• Dihydropirimidinase DeficiencyDihydropyrimidine dehydrogenase Deficiency
• Dihydropteridine reductase defect
• Duchenne Muscular Dystrophy
• Facioscapulohumeral Muscular Dystrophy
• Familial or Sporadic Fatal Insomnia
• Familial Spastic Paraplegia
• Farber Disease
• Freidreich’s Ataxia
• Frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in MAPT gene
• Frontotemporal Lobar Degeneration
• Galactosemia
• Galactosialidosis
• Gaucher Type 2 and Type 3
• Gerstmann-Straussler-Scheinker Disease
• Globular Glial Tauopathy
• Glutaric acidemia type 1
• Glycine encephalopathy, also known as non-ketotic hyperglycinemia
• Glycogen Storage-Lysosomal: Pompe Disease
• GM1 gangliosidosis
• GM2 gangliosidosis, also known as Tay-Sachs and Sandhoff Disease
• Guanidinoacetate methytransferase deficiency
• Guanosine triphosphate cyclohydrolase deficiency
• Homocysteine re-methylation defects
• Hunter Syndrome
• Hurler Syndrome
• Hypoxanthine-guanine phosophoribosyltransferase Deficiency, also known as Lesch-Nyhan disease
• Kearn Sayers Syndrome
• Krabbe
• Kuru
• L-2-hydroxyglutaric aciduria
• L-Arginine/glycine amidinotransferase deficiency
• Leigh syndrome
• Lesch-Nyhan
• leukodystrophy
• Lewy Body Disorders
• Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency
• Lysosomal Storage Diseases
• Mannosidosis
• Manosidosis alpha and beta
• Maple Syrup Urine Disease
• Metachromatic leukodystrophy
• Methylenetetrahydrofolate reductase deficiency severe variant
• Mitochondrial Depletion syndromes types 1 through 14
• Mitochondrial Encephalopathy Lactic Acidosis Stroke
• Mitochondrial Encephalopathy Ragged Red Fiber
• Mitochondrial neurogastrointestinal encephalopathy
• Monoamine oxidase deficiency
• Mucolipidoses
• Mucolipidoses Type II, also known as Inclusion Cell disease
• Mucolipidoses Type III, also known as pseudo-Hurler polydystrophy
• Mucopolysaccaridosis
• Mucopolysaccharidosis Type I, also known as Hurler Syndrome or Scheie Syndrome
• Mucopolysaccharidosis Type II, also known as Hunter Syndrome
• Mucopolysaccharidosis Type III, also known as Sanfilippo A and B
• Mucopolysaccharidosis Type IV, also known as Maroteaux-Lamy
• Mucopolysaccharidosis Type VII, also known as Sly
• Multiple Sulfatase deficiency Myoclonic epilepsy myopathy sensory ataxia
• Multiple System Atrophy
• Neimann Pick Type A and B
• Neimann Pick Type C
• Neonatal Adrenoleukodystrophy
• Neurodegeneration with brain iron accumulation
• Neurofibrillary Tangle dementia, also known as Primary Age-related Tauopathy
• Neuronal ceroid lipofuscinosis types 1-10 including Batten Disease
• Neuropathy, Ataxia, and Retinitis Pigmentosa
• Oligosaccharidoses
• Pantothenate Kinase Associated Neurodegeneration
• Parkinson’s Disease
• Pelizaeus-Merzbacher disease
• Peripheral neuropathy types 1 through 4
• Peroxisomal biosynthesis defects
• Pick Disease
• Polyol disorders
• Pompe Disease
• Primary Age-related Tauopathy
• Primary Lateral Sclerosis
• Prion Diseases
• Progressive Choreas: Huntington’s Disease
• Progressive dystonias DYT genes 1 through 20
• Progressive Muscular Atrophy
• Progressive Supranuclear Palsy
• Pterin-4-carbinolamine dehydratase defect
• Pyruvate Carboxylase Deficiency
• Pyruvate Dehydrogenase Deficiency
• Pyruvoyl-tetahydropterin synthase defect
• Refsum Disease
• Respiratory chain disorders complex 1 through 4 defects: Co Q biosynthesis defects
• RRM2B-related mitochondrial disease
• Salidosis
• Sandhoff Disease
• Sanfilippo A and B
• Scheie Syndrome
• Schindler
• Segawa Diease, also known as Dopamine Responsive Dystonia
• Sepiapterin reductase defect
• Sialidosis
• SLC 6A8
• Sly
• Spinal Muscular Atrophy
• Spinal-bulbar muscular atrophy
• Spinocerebellar ataxia
• Subacute necrotizing encephalopathy, also known as Leigh syndrome
• SUCLG1-related mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
• Tay-Sachs
• Thymidine Kinase
• Transactive response DNA-binding protein-43 (TDP-43) Proteinopathies
• Trifunctional protein deficiency
• Vascular dementia
• Wilson Disease
• X-linked adrenoleukodystrophy
• Zellweger syndrome

A treating physician of a patient suffering from an incurable neurodegenerative disease not listed in subsection (b) of this section may submit a request to the department to have a disease added.

*Source: 25 Texas Administratice Code 1, §1.61